Hypothesis · not a trading signal
Q3 FY2026 · Published 2026-08-13 · Source checked 2026-09-06
- 01 / What the issuer reported
- Revenue was $9.12bn, up 25%; company-reported free cash flow grew 14%.
- 02 / Our hypothesis — not established alpha
- More materials steps and advanced packaging may expand spend per chip even when wafer growth slows.
- 03 / What to measure next
- Foundry/DRAM mix, services, gross margin, cash conversion and customer capex excluding acquisition effects.
- 04 / What would challenge the thesis
- Reassess if growth depends on a short capacity surge rather than intensity/share gains, or cash conversion keeps weakening.
- 05 / Appropriate valuation method
- Mid-cycle earnings and DCF, separating service durability from equipment cyclicality.
- 06 / Still missing
- Missing: multi-cycle cash conversion and quantified process-intensity gains.
No measured consensus gap or approved price target. A familiar good business can still be an expensive stock.